53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
At CHEST 2025, held in Chicago, Illinois, Laurie Slovarp, PhD, CCC-SLP, professor at the University of Montana and certified speech pathologist, presented a poster on the development of a digital therapeutic designed to improve access to behavioral cough suppression therapy for patients with refractory chronic cough.
A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.
This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.
Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.
13.10.2023
Authors: Seung-Eun Lee, Matthew Rudd, Tae-Hwa Kim, Ji-Yoon Oh, Ji-Hyang Lee, Lola Jover, Peter M Small, Kian Fan Chung, Woo-Jung Song
This study focused on evaluating the Hyfe Cough Tracker. This mobile app, equipped with cough-counting AI algorithms, was used to monitor cough frequency in patients with chronic cough over a minimum period of one week. The research involved 65 subjects, with 43 completing the study.
Key findings included a median monitoring duration of 13.9 days with high adherence, variations in cough frequency, and a correlation between objective and subjective cough measures.
The study concluded that continuous monitoring is essential due to the significant day-to-day variability in cough frequency, emphasizing its importance in clinical practice and trials. The majority of participants found the monitoring helpful and easy to use, indicating the potential utility of such technology in managing chronic cough conditions
